Trial Profile
An observational cohort study of dolutegravir plus ritonavir-boosted darunavir in highly cART-experienced subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2016
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 29 Dec 2016 New trial record